Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1584 of 6351
-
New brain zaps could reignite motivation in stroke survivors
Symptom relief Recruiting nowApathy is a common set of symptoms seen in many people following a stroke. Apathy occurs when a person has lost motivation, becomes withdrawn, and stops doing things that used to be important to them. Apathy has a large negative impact on a person's quality of life, and can also …
Phase 1/2 • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
Smart wristband could help stroke patients use their weaker arm more
Symptom relief Recruiting nowThe proposed study is a two-arm randomized clinical trial designed to assess the effects of the StrokeWear system on clinical outcomes over a period of 6-months in subacute stroke survivors. The Intervention group will use StrokeWear system in combination to a motor and behaviora…
Sponsor: Spaulding Rehabilitation Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Boric acid inserts aim to cure yeast infections in new trial
Disease control OngoingThis is a Phase 3 clinical study to evaluate the efficacy, safety, and tolerability of boric acid 600 mg vaginal inserts in patients with VVC.
Phase 3 • Sponsor: pH-D Feminine Health LLC • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New pill shows promise for rare tumor in japanese patients
Disease control OngoingThis study is being conducted to characterize the efficacy and safety of nirogacestat in Japanese adults with progressing desmoid tumors/aggressive fibromatosis.
Phase 2 • Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New combo attack on pancreatic cancer: targeted pill meets chemo
Disease control Recruiting nowThe main objective of this trial is to evaluate the safety and tolerability of sotorasib combined with first-line chemotherapy for advanced pancreatic adenocarcinoma harboring KRAS p.G12C mutation.
Phase 1 • Sponsor: Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Can a pill boost brain blood flow in Alzheimer's? new trial aims to find out
Disease control By invitation onlyThe aim of this study is to determine whether pharmacological modulation of TSPO (with XBD173, 90mg twice daily, orally, for 28 days) improves neurovascular coupling (NVC) in AD relative to placebo. The main questions it aims to answer are: Does pharmacological modulation of TSP…
Phase 2 • Sponsor: Imperial College London • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New drug cocktail aims to beat tough lymphoma
Disease control Recruiting nowThe researchers are doing this study to see if alectinib in combination with duvelisib is a safe and effective time-limited treatment for people with relapsed or refractory ALK+ anaplastic large cell lymphoma (ALCL). The researchers will test different doses of the study drugs to…
Phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Heart valve trial asks: do we really need that extra artery test?
Disease control By invitation onlyThis study will be conducted in patients with severe aortic stenosis who are referred for transcatheter aortic valve implantation (TAVI). TAVI is the recommended treatment for severe aortic stenosis. Currently, before undergoing TAVI, most patients undergo a coronary angiography …
Sponsor: Rede Optimus Hospitalar SA • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Why are women getting lung cancer? a deep dive into risk factors
Knowledge-focused Recruiting nowLung cancer has been the most common and fatal type of cancer; indeed worldwide incidence of lung cancer is alarming. It is considered a leading cause of cancer- related deaths among males and females due to environmental pollution, occupational exposure, genetic susceptibility, …
Sponsor: Mansoura University Hospital • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
New cancer drug targets two proteins at once in early trial
Disease control Recruiting nowThis is an first-in-human, Phase I clinical study aimed at evaluating the safety, tolerability, PK, immunogenicity, and preliminary antitumor efficacy of AK146D1 for injection in advanced solid tumors.
Phase 1 • Sponsor: Akeso • Aim: Disease control
Last updated Jun 26, 2026 12:40 UTC
-
New heart failure drug shows promise in hospitalized patients
Disease control PausedThis study assesses the effects of the investigational drug COR-1167 in subjects hospitalised due to worsening of heart failure (HF)
Phase 2 • Sponsor: Corteria Pharmaceuticals • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New hope for lung cancer relapse: drug combo trial launches
Disease control Recruiting nowAim of this phase 2 study is to explore the safety and efficacy of thoracic re-irradiation +/- SBRT to oligometastases (\<3) followed after an interval of 2 weeks by durvalumab and ceralasertib for patients with thoracic relapses +/- oligometastases after PACIFIC or PACIFIC-like …
Phase 2 • Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New multilingual program aims to help smokers quit during lung cancer screening
Disease control Recruiting nowThis study aims to broaden the reach of the lung cancer screening (LCS) CONNECT program (NCT04149249, NCT06213532), by developing a version of the program to be available to multilingual communities. The CONNECT program encourages individuals who are undergoing lung cancer screen…
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can light therapy unlock stiff fingers?
Symptom relief Recruiting nowTrigger finger, also known as stenosing tenosynovitis, is one of the most common disorders affecting the hand. Its lifetime prevalence is 2-3%. Patients typically present with locking of the affected finger during flexion and painful catching during extension. In mild cases, pain…
Sponsor: Dokuz Eylul University • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
New HIV vaccine duo enters first human safety trial
Vaccine OngoingThis is a phase 1, first-in-human (FIH) trial for two vaccines, DV700P-RNA and DV701B1.1-RNA. This means it is the first time these study products are being tested in people. The purpose of this study is to see if the study products are safe, if people are able to take them with…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Jun 27, 2026 08:04 UTC
-
New stent aims to cut infections and hospital visits for kidney and cancer patients
Symptom relief Recruiting nowUrological stents and catheters often lead to inflammation, causing pain and infection in the urinary tract. Moreover, 80% of stents are associated with pain, negatively impacting on QoL and mental health. Offering novel designs with significantly lower E\&B leads to a reduction …
Sponsor: University of Southampton • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
AI could uncover silent heart failure in diabetes patients
Knowledge-focused Recruiting nowA pragmatic electronic health record (EHR) based randomized controlled trial to evaluate the utility of providing Ultromics EchoGo analysis results and recommendations for HF risk prevention therapies using an EHR embedded clinical decision support tool.
Sponsor: University of Texas Southwestern Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
New hope for dementia psychosis: experimental drug ACP-204 enters key trial
Symptom relief Recruiting nowMulticenter, randomized, 6-week, double-blind, placebo-controlled, parallel-group, Phase 2 study in subjects with LBDP.
Phase 2 • Sponsor: ACADIA Pharmaceuticals Inc. • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC
-
New catheter aims to clear Hard-to-Treat heart blockages
Disease control By invitation onlyThis is a study to evaluate the safety and effectiveness of the Acolyte Catheter System used in CTO-PCI procedures. The system will be used for the placement and positioning of guidewires and catheters in the coronary vasculature for the treatment of patients with coronary chroni…
Sponsor: Elumn8 Medical • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New radiation drug targets Hard-to-Treat cancers
Disease control Recruiting nowThe main purpose of this study is to evaluate safety, tolerability, and efficacy of LY4257496 alone and as part of relevant standard of care (SOC) combination therapy in participants with Gastrin-releasing Peptide Receptor (GRPR)-positive advanced cancer, including but not limite…
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC